New rapid test could save thousands of febrile children in africa
NCT ID NCT06422338
First seen Feb 18, 2026 · Last updated Jun 20, 2026 · Updated 13 times
Summary
This study tests a new rapid triage test for children with fever in sub-Saharan Africa. The test measures a protein called suPAR to help doctors decide whether to admit or discharge a child. Over 5,000 children will be randomly assigned to either standard care or standard care plus the suPAR test. The goal is to see if the test reduces inappropriate discharges and deaths.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILD, ONLY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CERMEL Centre de Recherches Médicales de Lambaréné
RECRUITINGLambaréné, Moyen-Ogooué Province, 242, Gabon
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mopeia Sede Health Centre
RECRUITINGMopeia, Mozambique
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
suPAR point-of-care test
What this could lead to
If successful, this test could help doctors quickly identify which febrile children need hospital care, potentially saving lives and reducing unnecessary admissions.
What could go wrong
This is a large trial, but the test is new and may not work better than current methods. There is also a risk of incorrect results leading to wrong decisions.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.